<p>以 33.3 倍的市盈率（&#34;P/E&#34;）来看，<strong>VeriSign, Inc.</strong>（纳斯达克代码：VRSN）目前可能发出非常看跌的信号，因为美国几乎一半的公司市盈率低于 19 倍，甚至低于 11 倍的市盈率也并不罕见。不过，仅仅将市盈率表面化是不明智的，因为可能有解释说明其如此高的原因。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>最近一段时间对 VeriSign 并不利，因为其盈利增长速度慢于大多数其他公司。一个可能性是，市盈率之所以高，是因为投资者认为这种乏力的盈利表现将显著改善。如果没有，那么现有股东可能会对股价的可行性感到非常紧张。</p>
<p>查看我们对 VeriSign 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36216-pe-multiple-vs-industry-1-dark-2/1758822557824?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36216-pe-multiple-vs-industry-1-dark-2/1758822557824"/></p>
<p>纳斯达克 GS:VRSN 市盈率与行业比较 2025 年 9 月 25 日</p>
<p>如果你想了解分析师对未来的预测，可以查看我们关于 VeriSign 的 <strong>免费</strong> 报告。</p>
<h2>增长指标告诉我们高市盈率的什么？</h2>
<p>VeriSign 的市盈率对于一家预计将实现强劲增长的公司来说是典型的，重要的是，其表现将远超市场。</p>
<p>回顾过去，我们看到该公司在过去一年几乎没有可言的每股收益增长。尽管如此，得益于早期的增长，EPS 在三年前的基础上总共提升了 16%。因此，可以公平地说，该公司的盈利增长最近一直不稳定。</p>
<p>展望未来，覆盖该公司的三位分析师的估计表明，未来三年每年的盈利应增长 13%。而市场预计每年仅增长 11%，因此该公司有望实现更强的盈利结果。</p>
<p>鉴于此，VeriSign 的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
<h2>最终结论</h2>
<p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
<p>正如我们所怀疑的，我们对 VeriSign 的分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。目前，股东对市盈率感到满意，因为他们相当自信未来的盈利不会受到威胁。在这种情况下，很难想象股价在近期内会大幅下跌。</p>
<p>还值得注意的是，我们发现了 <strong>VeriSign 的 3 个警告信号</strong>（其中 1 个不容忽视！），你需要考虑这些因素。</p>
<p>如果你对 VeriSign 的业务实力 <strong>不确定</strong>，为什么不探索一下我们互动式的股票列表，寻找一些你可能错过的基本面扎实的其他公司呢？</p>

威瑞信

<p>VeriSign, Inc.（纳斯达克代码：VRSN）的市盈率高达 33.3 倍，显示出与美国平均市盈率不足 19 倍相比的看跌信号。尽管盈利增长缓慢，分析师预测未来三年年均增长率为 13%，这表明投资者对未来表现持乐观态度。当前，股东似乎对公司的前景充满信心，因此股价大幅下跌的可能性不大。然而，关于 VeriSign 的商业健康状况，有三个警示信号需要考虑</p>

<p>With a price-to-earnings (or &#34;P/E&#34;) ratio of 33.3x <strong>VeriSign, Inc.</strong> (NASDAQ:VRSN) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 19x and even P/E's lower than 11x are not unusual. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>以 33.3 倍的市盈率（&#34;P/E&#34;）来看，<strong>VeriSign, Inc.</strong>（纳斯达克代码：VRSN）目前可能发出非常看跌的信号，因为美国几乎一半的公司市盈率低于 19 倍，甚至低于 11 倍的市盈率也并不罕见。不过，仅仅将市盈率表面化是不明智的，因为可能有解释说明其如此高的原因。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>Recent times haven't been advantageous for VeriSign as its earnings have been rising slower than most other companies. One possibility is that the P/E is high because investors think this lacklustre earnings performance will improve markedly. If not, then existing shareholders may be very nervous about the viability of the share price.</p>
<div class="lb-trans"><p>最近一段时间对 VeriSign 并不利，因为其盈利增长速度慢于大多数其他公司。一个可能性是，市盈率之所以高，是因为投资者认为这种乏力的盈利表现将显著改善。如果没有，那么现有股东可能会对股价的可行性感到非常紧张。</p>
</div><p>Check out our latest analysis for VeriSign</p>
<div class="lb-trans"><p>查看我们对 VeriSign 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36216-pe-multiple-vs-industry-1-dark-2/1758822557824" alt="" original-src="https://images.simplywall.st/asset/chart/36216-pe-multiple-vs-industry-1-dark-2/1758822557824"/></p>
<p>NasdaqGS:VRSN Price to Earnings Ratio vs Industry September 25th 2025</p>
<div class="lb-trans"><p>纳斯达克 GS:VRSN 市盈率与行业比较 2025 年 9 月 25 日</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on VeriSign.</p>
<div class="lb-trans"><p>如果你想了解分析师对未来的预测，可以查看我们关于 VeriSign 的 <strong>免费</strong> 报告。</p>
</div><h2>What Are Growth Metrics Telling Us About The High P/E?</h2>
<div class="lb-trans"><h2>增长指标告诉我们高市盈率的什么？</h2>
</div><p>VeriSign's P/E ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the market.</p>
<div class="lb-trans"><p>VeriSign 的市盈率对于一家预计将实现强劲增长的公司来说是典型的，重要的是，其表现将远超市场。</p>
</div><p>Taking a look back first, we see that there was hardly any earnings per share growth to speak of for the company over the past year. Regardless, EPS has managed to lift by a handy 16% in aggregate from three years ago, thanks to the earlier period of growth. Therefore, it's fair to say that earnings growth has been inconsistent recently for the company.</p>
<div class="lb-trans"><p>回顾过去，我们看到该公司在过去一年几乎没有可言的每股收益增长。尽管如此，得益于早期的增长，EPS 在三年前的基础上总共提升了 16%。因此，可以公平地说，该公司的盈利增长最近一直不稳定。</p>
</div><p>Shifting to the future, estimates from the three analysts covering the company suggest earnings should grow by 13% per year over the next three years. With the market only predicted to deliver 11% each year, the company is positioned for a stronger earnings result.</p>
<div class="lb-trans"><p>展望未来，覆盖该公司的三位分析师的估计表明，未来三年每年的盈利应增长 13%。而市场预计每年仅增长 11%，因此该公司有望实现更强的盈利结果。</p>
</div><p>In light of this, it's understandable that VeriSign's P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>鉴于此，VeriSign 的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最终结论</h2>
</div><p>Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
</div><p>As we suspected, our examination of VeriSign's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. It's hard to see the share price falling strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我们所怀疑的，我们对 VeriSign 的分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。目前，股东对市盈率感到满意，因为他们相当自信未来的盈利不会受到威胁。在这种情况下，很难想象股价在近期内会大幅下跌。</p>
</div><p>It is also worth noting that we have found <strong>3 warning signs for VeriSign</strong> (1 shouldn't be ignored!) that you need to take into consideration.</p>
<div class="lb-trans"><p>还值得注意的是，我们发现了 <strong>VeriSign 的 3 个警告信号</strong>（其中 1 个不容忽视！），你需要考虑这些因素。</p>
</div><p>If you're <strong>unsure about the strength of VeriSign's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果你对 VeriSign 的业务实力 <strong>不确定</strong>，为什么不探索一下我们互动式的股票列表，寻找一些你可能错过的基本面扎实的其他公司呢？</p>
</div>

威瑞信公司（NASDAQ:VRSN）的股价是否与投资者的看法一致